Jennifer Good

2023

In 2023, Jennifer Good earned a total compensation of $1.7M as President and Chief Executive Officer at Trevi Therapeutics, a 88% increase compared to previous year.

Compensation breakdown

Bonus$229,075
Option Awards$851,399
Salary$596,924
Other$9,900
Total$1,687,298

Good received $851.4K in option awards, accounting for 50% of the total pay in 2023.

Good also received $229.1K in bonus, $596.9K in salary and $9.9K in other compensation.

Rankings

In 2023, Jennifer Good's compensation ranked 663rd out of 2,878 executives tracked by ExecPay. In other words, Good earned more than 77.0% of executives.

ClassificationRankingPercentile
All
663
out of 2,878
77th
Division
Manufacturing
376
out of 1,582
76th
Major group
Chemicals And Allied Products
257
out of 891
71st
Industry group
Drugs
253
out of 854
70th
Industry
Pharmaceutical Preparations
162
out of 614
74th
Source: SEC filing on April 26, 2024.

Good's colleagues

We found two more compensation records of executives who worked with Jennifer Good at Trevi Therapeutics in 2023.

2023

Thomas Sciascia

Trevi Therapeutics

Chief Scientific Officer

2023

David Clark

Trevi Therapeutics

Chief Medical Officer

News

In-depth

You may also like